Benjamin Liou

Title: The Innovations of Benjamin Liou

Introduction

Benjamin Liou is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of rare diseases. With a total of 3 patents, his work focuses on innovative therapies that address critical health issues.

Latest Patents

One of his latest patents is titled "Pharmacological therapy for neuronopathic Gaucher disease." This patent relates to methods and compositions for treating Gaucher disease, specifically types II and III neuronopathic Gaucher disease (nGD). The methods involve administering an effective amount of a ryanodine receptor inhibitor or a pharmaceutically acceptable salt thereof to individuals in need. Another significant patent is "Lysosomal protein targeting sequence and therapeutic applications of same." This disclosure outlines methods for treating diseases such as lysosomal storage diseases and neurodegenerative diseases. It also includes compositions that may comprise acid β-glucosidase (GCase) protein with mutations, peptides of acid β-glucosidase, and related DNA vectors and cell lines.

Career Highlights

Benjamin Liou is affiliated with the Children's Hospital Medical Center, where he applies his expertise in pharmacology to advance medical treatments. His work has been instrumental in developing therapies that improve the quality of life for patients suffering from complex diseases.

Collaborations

He collaborates with esteemed colleagues such as Gregory A Grabowski and Ying Sun, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Benjamin Liou's contributions to pharmacology and his innovative patents highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that address critical health challenges.